FDA Resources for Device Development from the 2022 NeuroAbilities Virtual Symposium
Panel Session Resources Shared by the U.S. Food & Drug Administration (FDA) on March 31, 2022
For a complete recording of this session with captions and sign interpretation, please visit our YouTube Channel.
Neuro-specific:
-
Overview on Neurological Devices by the FDA
-
FDA Perspectives on the Regulation of Neuromodulation Devices (article)
-
Webinar on Implanted BCI Devices for Patients with Paralysis or Amputation - Non-clinical Testing and Clinical Considerations Final Guidance
-
Implanted Brain-Computer Interface (BCI) Devices for Patients with Paralysis or Amputation - Non-clinical Testing and Clinical Considerations (download)
- FDA Regulation of Neurological and Physical Medicine Devices: Access to Safe and Effective Neurotechnologies for All Americans (article)
Other Resources:
-
Center for Devices and Radiological Health (CDRH) Learn
-
CDRH News (RSS and email updates)
-
Clinical Trials and IDE Guidance Documents
- How to Market Your Device
-
Clinical Trials Regulatory Information
-
Significant Risk/Non-Significant Risk Guidance Documents
- Information Sheet Guidance for Medical Device Studies
- CDRH Medical Device Development Tools Program